US 8712696
Methods of prognosing a rheumatoid arthritis remission phenotype
granted A61PA61P37/06
Quick answer
US patent 8712696 (Methods of prognosing a rheumatoid arthritis remission phenotype) held by PROGENIKA BIOPHARMA, S.A. expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PROGENIKA BIOPHARMA, S.A.
- Grant date
- Tue Apr 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P37/06